Data on SARS-CoV-2 seroprevalence in kidney transplant recipients (KTR) remain rare. We sought to shed further light on this issue by conducting a single-center study in a kidney transplant center located in one of the France’s highest risk zone (Grand Est) for Covid-19 during the initial disease outbreak.
To this aim, we used a survey approach coupled with systematic investigation of SARS-CoV-2 serology in a cohort of 1390 KTR.
SARS-CoV-2 serologies were available for 780 survey respondents, among whom 48 had anti-SARS-CoV-2 antibodies (total seroprevalence: 6.2%). Thirty-five of the 48 seropositive KTR had previously received a diagnosis of Covid-19, whereas the remaining 13 patients were not known to be infected (8 asymptomatic cases). Specifically, 18.7% of seropositive KTR and 1.1% of the entire cohort were asymptomatic. Household exposure was found to markedly increase the risk of SARS-CoV-2 transmission.
Our findings demonstrate that the overall SARS-CoV-2 seroprevalence in KTR living in one of the France’s highest risk zone for Covid-19 during the first French lockdown was as low as 6.3%. A rapid and strict implementation of protective measures could have significantly mitigated virus spread even in an area of high virus circulation.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
About The Expert
Sophie Caillard
Ilies Benotmane
Céline Meidinger
Vanessa Jegou
Sandra Ludwiller
Anne Rihon
Audrey Desmarquets
Lucille Steinmetz
Murielle Morvan
Karima Kedjam
Amandine Bigot
Danielle Roy
Dominique Schmitt
David Marx
Xavier Bassand
Peggy Perrin
Gabriela Gautier Vargas
Noelle Cognard
Jérome Olagne
Laura Braun
Francoise Heibel
Jonas Martzloff
Bruno Moulin
Samira Fafi Kremer
References
PubMed